Income Tax Expense (Benefit) of TC BioPharm (Holdings) plc from 31 Dec 2022 to 31 Dec 2024

Taxonomy & unit
us-gaap: GBP
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
TC BioPharm (Holdings) plc annual and quarterly Income Tax Expense (Benefit) in GBP history and change rate from 31 Dec 2022 to 31 Dec 2024.
  • TC BioPharm (Holdings) plc Income Tax Expense (Benefit) for the quarter ending 31 Mar 2024 was £110,742, a 72% increase year-over-year.
  • TC BioPharm (Holdings) plc annual Income Tax Expense (Benefit) for 2024 was £651,971, a 40% increase from 2023.
  • TC BioPharm (Holdings) plc annual Income Tax Expense (Benefit) for 2023 was £1,088,729, a 37% increase from 2022.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Annual (GBP)
Income Tax Expense (Benefit), YoY Annual Change (%)
Income Tax Expense (Benefit), Quarterly (GBP)
Income Tax Expense (Benefit), YoY Quarterly Change (%)

TC BioPharm (Holdings) plc Annual Income Tax Expense (Benefit) (GBP)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 £651,971 +£436,758 +40% 01 Jan 2024 31 Dec 2024 20-F 09 May 2025 2024 FY
2023 £1,088,729 +£631,271 +37% 01 Jan 2023 31 Dec 2023 20-F 09 May 2025 2024 FY
2022 £1,720,000 01 Jan 2022 31 Dec 2022 20-F 09 May 2025 2024 FY

TC BioPharm (Holdings) plc Quarterly Income Tax Expense (Benefit) (GBP)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 £110,742 +£289,258 +72% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q1 2023 £400,000 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.